Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy
Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. Cumulative drug therapy of CDDP is known to produce severe oxidative damage. It mainl...
Saved in:
Main Authors: | Naini Bhadri, Tejaswi Sanji, Hariprasad Madakasira Guggilla, Rema Razdan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2013/565813 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Repeated Cisplatin and Monosodium Glutamate on Visceral Sensitivity in Rats
by: Yolanda López-Tofiño, et al.
Published: (2024-12-01) -
Therapeutic Effects of the Combination of Alpha-Lipoic Acid (ALA) and Coenzyme Q10 (CoQ10) on Cisplatin-Induced Nephrotoxicity
by: Eman Aly Khalifa, et al.
Published: (2020-01-01) -
A Survey on the Evaluation of Monosodium Glutamate (MSG) Taste in Austria
by: Emilia Iannilli, et al.
Published: (2024-12-01) -
Low Concentrations of Monosodium Glutamate (MSG) are Safe in Male Drosophila Melanogaster.
by: Keneth Iceland, Kasozi, et al.
Published: (2023) -
Safety assessment of monosodium glutamate based on intestinal function and flora in mice
by: Jinzhao Xu, et al.
Published: (2022-01-01)